Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Helen Boucher

Transplant/Immunocompromised States · Tufts

View

Dr. Sara Dong

Transplant/Immunocompromised States · Boston Children's Hospital

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Keith Kaye

General ID · RU

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Kelly Dooley

Mycobacterial Disease · Vanderbilt

View

Dr. Erin Bonura

General ID · OHSU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    ERDr. Emily Rosen

    Dr. Emily Rosen

    Infectious Disease · Transplant/Immunocompromised States
    Fred Hutch Cancer Center
    emilyrosen

    Research

    P-1873. Infectious Disease Work Load Index: A Systematic Measurement of Patient Acuity and Overall Work Volume

    2026

    Via Open Forum Infectious Diseases

    Research

    Utilization and Yield of a Stool Enteric Pathogen Panel in Hospitalized Patients with Cancer with Community vs Hospital-onset Diarrhea

    2026

    Via Antimicrobial Stewardship & Healthcare Epidemiology

    Research

    Tackling antimicrobial resistance in people who are immunocompromised: leveraging diagnostic and antimicrobial stewardship

    2026

    Via Lancet Infect Dis

    Oct 28, 2026Journal Article

    Diagnostic Yield of Repeat Blood Cultures and Risk Factors for Bloodstream Infection in Persistent Febrile Neutropenia.

    ​
    ​

    Written by 2 Roon authors & 10 others

    Via Clinical Infectious Diseases

    Research

    P-1597. Timing and Microbiology of Late Positive Blood Cultures in Hematology/Oncology Patients with Persistent Febrile Neutropenia

    2025

    Via Open Forum Infectious Diseases

    Aug 29, 2025Journal Article

    Limited yield of SARS-CoV-2 screening in asymptomatic hematopoietic cell transplant and chimeric antigen receptor T-cell therapy patients.

    ​
    ​
    ​+1

    Written by 3 Roon authors & 8 others

    Via Antimicrobial Stewardship & Healthcare Epidemiology

    Research

    Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID-19 infection at an ambulatory cancer center

    2024

    Via Transpl Infect Dis

    Research

    Changing the culture of blood cultures: Opportunities for diagnostic stewardship in febrile neutropenia

    2024

    Via Transpl Infect Dis

    Research

    Epidemiology and Outcomes of Recurrent C Difficile Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study

    2024

    Via Open Forum Infect Dis

    Research

    Author Response to "COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-cell Recipients: Correspondence"

    2024

    Via Transplant Cell Ther